Vasoreactivity of Chorionic Plate Arteries in Response to Vasoconstrictors Produced by Preeclamptic Placentas

Placenta

Volumn 28, Issue 5-6, 2007, Pages 498-504

  Benoit, C ^a,b   Zavecz, J ^a   Wang, Y ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

ANG II; ET; Placenta; Preeclampsia; TX; Vasoactivity

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; CHYMASE INHIBITOR; CHYMOSTATIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; THROMBOXANE; THROMBOXANE RECEPTOR BLOCKING AGENT; VASOCONSTRICTOR AGENT;

ARTICLE; AUTONOMIC INNERVATION; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CHORION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DELIVERY; DISEASE ASSOCIATION; EXPERIMENTAL MODEL; FEMALE; FETOPLACENTAL UNIT; HUMAN; HUMAN TISSUE; PLACENTA CIRCULATION; PLACENTA PERFUSION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TROPHOBLAST; VASOCONSTRICTION;

ARTERIES; CHORION; FEMALE; HUMANS; HYDRAZINES; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, THROMBOXANE; REFERENCE VALUES; VASOCONSTRICTOR AGENTS;

EID: 34247155314     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2006.09.002     Document Type: Article

References (48)

1. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
2. Dechend R., Homuth V., Wallukat G., Kreuzer J., Park J.K., Theuer J., et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 101 (2000) 2382-2387
3. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., and McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161 (1989) 1200-1204
4. Gant N.F., Chand S., Worley R.J., Whalley P.J., Crosby U.D., and MacDonald P.C. A clinical test useful for predicting the development of acute hypertension in pregnancy. Am J Obstet Gynecol 120 (1974) 1-7
5. Gant N.F., Daly G.L., Chand S., Whalley P.J., and MacDonald P.C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 52 (1973) 2682-2689
6. Xia Y., Wen H., Bobst S., Day M.C., and Kellems R.E. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Ivestig 10 (2003) 82-93
7. Wang Y., Walsh S.W., Guo J.D., and Zhang J. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 165 (1991) 1695-1700
8. Walsh S.W. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 152 (1985) 335-340
9. Schiff E., Ben-Baruch G., Peleg E., Rosenthal T., Alcalav M., Devir M., et al. Immunoreactive circulating endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol 166 (1992) 624-628
10. Myatt L. Current topic: control of vascular resistance in the human placenta. Placenta 13 (1992) 329-341
11. Granger J.P., Alexander B.T., Bennett W.A., and Khalil R.A. Pathophysiology of pregnancy-induced hypertension. Am J Hypertens 14 (2001) 178S-185S
12. Nielsen A.H., Schauser K.H., and Poulsen K. Current topic: the uteroplacental renin-angiotensin system. Placenta 21 (2000) 468-477
13. Taira H., Mizutani S., Narita O., and Tomoda Y. Angiotensin I-converting enzyme in human placenta. Placenta 6 (1985) 543-549
14. Skinner S.L., Lumbers E.R., and Symonds E.M. Renin concentration in human fetal and maternal tissues. Am J Obstet Gynecol 101 (1968) 529-533
15. Ito M., Itakura A., Ohno Y., Nomura M., Senga T., Nagasaka T., et al. Possible activation of the renin-angiotensin system in the feto-placental unit in preeclampsia. J Clin Endocrinol Metab 87 (2002) 1871-1878
16. Broughton Pipkin F., Craven D.J., and Symonds E.M. The uteroplacental renin-angiotensin system in normal and hypertensive pregnancy. Contributions Nephrol 25 (1981) 49-52
17. Walsh S.W., and Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 80 (1995) 1888-1893
18. Bowen R.S., Zhang Y., Gu Y., Lewis D.F., and Wang Y. Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia conditions. Placenta 26 (2005) 402-409
19. Levin E. Endothelins. N Engl J Med 333 (1995) 356-362
20. Le S.Q., Wasserstrum N., Mombouli J.V., and Vanhoutte P.M. Contractile effect of endothelin in human placental veins: role of endothelium prostaglandins and thromboxane. Am J Obstet Gynecol 169 (1993) 919-924
21. Singh H.J., Rahman A., Larmie E.T., and Nila A. Endothelin-1 in feto-placental tissues from normotensive pregnant women and women with pre-eclampsia. Acta Obstet Gynecol Scand 80 (2001) 99-103
22. Roberts J. Angiotensin-1 receptor autoantibodies: a role in the pathogenesis of preeclampsia?. Circulation 101 (2000) 2335-2337
23. Li X., Shams M., Zhu J., Khalig A., Wilkes M., Whittle M., et al. Cellular localization of AT1 Receptor mRNA and Protein in Normal Placenta and its Reduced Expression in Intrauterine Growth Restriction. J Clin Invest 101 (1998) 442-454
24. Knock G.A., Sullivan M.H., McCarthy A., Elder M.G., Polak J.M., and Wharton J. Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies. J Pharmacol Exp Ther 271 (1994) 1007-1015
25. Kalenga M.K., de Gasparo M., de Hertogh R., Whitebread S., Vankrieken L., and Thomas K. Angiotensin II receptors in the human placenta are type AT1. Reprod Nutr Dev 31 (1991) 257-267
26. Boura A.L., Gude N.M., King R.G., Mak K.K., and Walters W.A. Characterization of thromboxane A2 receptors in the human fetal placental vessels and umbilical vein. Clin Exp Pharmacol Physiol 13 (1986) 83-86
27. Hirata M., Hayashi Y., Ushikubi F., Yokota Y., Kadeyama R., Nakanishi S., et al. Cloning and expression of cDNA for human thromboxane A2 receptor. Nature 349 (1991) 617-620
28. Wilkes B.M., Macica C., and Mento P.F. Endothelin conversion and receptor characterization in human placental arteries. Am J Physiol 267 (1994) 325-415
29. Wang Y., Adair C., Weeks J.W., Lewis D.F., and Alexander J.S. Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia. J Soc Gynecol Investig 6 (1999) 136-141
30. Wang Y., Gu Y., Philibert L., and Lucas M.J. Neutrophil activation induced by placental factors in normal and pre-eclamptic pregnancies in vitro. Placenta 22 (2001) 560-565
31. Zavecz J.H., Bueno O., Maloney R.E., O'Donnell J.M., Roerig S.C., and Battarbee H.D. Cardiac excitation-contraction coupling in the portal hypertensive rat. Am J Physiol Gastointest Liver Physiol 279 (2000) g28-g39
32. Bertrand C., Duperron L., and St-Louis J. Umbilical and placental vessels: modifications of their mechanical properties in preeclampsia. Am J Obstet Gynecol 168 (1993) 1537-1546
33. Wareing M., and Baker P.N. Vasoconstriction of small arteries isolated from the human placental chorionic plate in normal and compromised pregnancy. Hypertens Pregnancy 23 (2004) 237-246
34. Jain V., Lim M., Longo M., and Fisk N. Inhibitory effect of erythropoietin on contractility of human chorionic plate vessels. Am J Obstet Gynecol 194 (2006) 246.e1-246.e7
35. Estan L., Abad A., Morales-Olivas F.J., and Serra-Serra V. Isolated human chorionic vascular reactivity: Technical considerations for fresh preparations. Gen Pharmac 30 (1998) 89-93
36. Tom B., Gerrelds I.M., Scalbert E., Stegmann A.P., Boomsma F., Saxena P.R., et al. ACE-versus chymase-dependent antiotensin II generation in human coronary arteries: a Matter of Efficiency?. Arterioscler Thromb Vasc Biol 23 (2003) 251-256
37. MaasenVanDenBrink A., de Vries R., Saxena P.R., Schalekamp M., and Danser A.H.J. Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase. Cardiovascular research 44 (1999) 407-415
38. Wilkes B.M., and Mento P. Bradykinin-induced vasoconstriction and thromboxane release in perfused human placenta. Am J Physiol 254 (1988) E681-E686
39. Naruse M., Naruse K., Kurimoto F., Sakurai H., Yoshida S., Toma H., et al. Evidence for the existence of des-Asp1-angiotensin II in human uterine and adrenal tissues. J Clin Endocrinol Metab 61 (1985) 480-483
40. Paul M., Wagner J., and Dzau V.J. Gene expression of the renin-angiotensin system in human tissues: quantitative analysis by the polymerase chain reaction. J Clin Invest 91 (1993) 2058-2064
41. Shah D. Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Renal Physiol 288 (2005) 614-625
42. Khalil R.A., and Granger J.P. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 283 (2002) R29-R45
43. Urata H., and Ganten D. Cardiac angiotensin II formation: the angiotensin-1 converting enzyme and human chymase. Eur Heart J 14 (1993) 177-182
44. Wang Y., Gu Y., Zhang Y., Lewis D.F., Alexander J.S., and Granger D.N. Increased chymotrypsin-like protease (chymase) expression and activity in placentas from women with preeclampsia. Placenta (2006) Epub ahead of print
45. Sand A.E., Ostlund E., Andersson E., and Fried G. Endothelin-induced contractions in placental arteries is mediated by both ETa- and ETb receptors. Acta Physiol Scand 163 (1998) 227-234
46. Sawicki G., Radomski M.W., Winkler-Lowen B., Krzymien A., and Guilbert L.J. Polarized release of matrix metalloproteinase-2 and -9 from cultured human placental syncytiotrophoblasts. Biol Reprod 63 5 (2000) 1390-1395
47. Wang Y., Zhang Y., Lewis D.F., Gu Y., Li H., Granger D.N., et al. Protease chymotrypsin mediates the endothelial expression of P- and E-selectin, but not ICAM and VCAM, induced by placental trophoblasts from pre-eclamptic pregnancies. Placenta 24 (2003) 851-861
48. Wang Y., Lewis D.F., Gu Y., Zhang Y., Alexander J.S., and Granger D.N. Placental trophoblast-derived factors diminish endothelial barrier function. J Endocrinol 89 5 (2004) 2421-2428